tiprankstipranks
Trending News
More News >
IBI Investment House Ltd. (IL:IBI)
:IBI
Israel Market
Advertisement

Ibi Inv House (IBI) AI Stock Analysis

Compare
1 Followers

Top Page

IL:IBI

Ibi Inv House

(IBI)

Rating:70Outperform
Price Target:
27,280.00
â–²(10.00% Upside)
Ibi Inv House's overall stock score is driven by its strong financial performance and stable valuation. The company's profitability and cash flow management are commendable, though recent revenue decline and slight negative cash flow growth warrant attention. Technical analysis indicates bearish momentum, suggesting potential short-term weakness. The stock's valuation is reasonable, with an attractive dividend yield, making it a stable investment option with income potential.

Ibi Inv House (IBI) vs. iShares MSCI Israel ETF (EIS)

Ibi Inv House Business Overview & Revenue Model

Company DescriptionIbi Inv House (IBI) is a financial services company specializing in investment management and advisory services. Operating primarily in the investment sector, IBI offers a range of products including mutual funds, private equity, and asset management services tailored to individual and institutional investors. The firm leverages advanced analytics and market insights to help clients achieve their financial goals through strategic investment solutions.
How the Company Makes MoneyIbi Inv House generates revenue primarily through management fees charged on the assets under management (AUM) in its investment funds. Additionally, the company earns performance fees tied to the success of its private equity investments and other managed portfolios. Advisory fees from consulting services provided to clients and institutions also contribute to its revenue stream. Significant partnerships with financial institutions and technology firms enhance its market presence and enable access to a broader client base, further driving earnings.

Ibi Inv House Financial Statement Overview

Summary
Ibi Inv House demonstrates a strong financial position with solid growth in revenue and profitability metrics. The company maintains a conservative leverage strategy and effective cash flow management. Despite minor fluctuations in recent revenue and equity figures, the overall outlook remains positive with strong margins and cash conversion ratios, indicating a well-managed company with potential for continued growth and stability.
Income Statement
85
Very Positive
The company has demonstrated strong revenue growth, particularly in recent years, with a Revenue Growth Rate of 25.99% from 2022 to 2023. Gross Profit Margin is impressive at 98.45% in the TTM period, indicating efficient cost management. Net Profit Margin stands at a healthy 20.38%, reflecting strong profitability. Both EBIT Margin and EBITDA Margin are robust at 37.02% and 46.99%, respectively, showcasing operational efficiency. However, the decline in total revenue from 2024 to the TTM period warrants attention.
Balance Sheet
78
Positive
The company's balance sheet reflects a solid financial position with an improving Equity Ratio of 44.96% in the TTM period, suggesting a stable capital structure. The Debt-to-Equity Ratio is low at 0.29, indicating conservative leverage. Return on Equity is strong at 19.93% for the TTM period, highlighting effective utilization of equity. However, a decrease in Stockholders' Equity from 2023 to TTM suggests potential concerns over retained earnings or shareholder distributions.
Cash Flow
80
Positive
The company exhibits strong cash flow management, with a positive Free Cash Flow Growth Rate of 4.32% from 2023 to 2024. The Operating Cash Flow to Net Income Ratio is healthy at 1.48 in the TTM period, indicating effective conversion of earnings into cash. The Free Cash Flow to Net Income Ratio is 1.28, reflecting robust cash generation capabilities. However, fluctuations in investing cash flow over recent periods suggest potential volatility in investment activities.
BreakdownDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.04B791.55M660.61M589.40M435.79M
Gross Profit696.21M511.24M417.09M397.75M279.51M
EBITDA368.28M281.08M212.29M231.00M150.50M
Net Income178.14M156.46M90.76M139.58M81.94M
Balance Sheet
Total Assets1.85B1.27B1.08B1.13B1.02B
Cash, Cash Equivalents and Short-Term Investments519.23M453.00M246.53M442.65M297.47M
Total Debt243.90M201.26M154.42M334.90M197.25M
Total Liabilities750.27M539.07M399.48M521.39M469.80M
Stockholders Equity899.76M686.62M640.44M575.47M522.10M
Cash Flow
Free Cash Flow218.35M207.56M33.63M190.60M67.73M
Operating Cash Flow249.28M269.65M49.51M197.55M78.27M
Investing Cash Flow-97.88M-269.38M-32.48M36.90M-83.19M
Financing Cash Flow-141.00K-37.48M-80.76M-196.36M25.17M

Ibi Inv House Technical Analysis

Technical Analysis Sentiment
Negative
Last Price24800.00
Price Trends
50DMA
24937.80
Negative
100DMA
23616.51
Positive
200DMA
20440.44
Positive
Market Momentum
MACD
-167.56
Positive
RSI
43.84
Neutral
STOCH
30.30
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IL:IBI, the sentiment is Negative. The current price of 24800 is below the 20-day moving average (MA) of 26668.50, below the 50-day MA of 24937.80, and above the 200-day MA of 20440.44, indicating a neutral trend. The MACD of -167.56 indicates Positive momentum. The RSI at 43.84 is Neutral, neither overbought nor oversold. The STOCH value of 30.30 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IL:IBI.

Ibi Inv House Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
76
Outperform
1.22B12.36
5.66%270.98%29.28%
70
Outperform
3.50B19.67
4.54%42.11%10.55%
65
Neutral
2.90B9.71
7.59%25.90%68.30%
62
Neutral
C$15.75B6.6513.72%5.94%21.41%-9.85%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
IL:IBI
Ibi Inv House
24,180.00
12,814.59
112.75%
IL:IDIN
Idi Insur
19,740.00
9,799.66
98.58%
IL:ATRY
Atreyu Cap
8,103.00
2,697.40
49.90%

Ibi Inv House Corporate Events

Ibi Inv House Ltd. Announces 2024 Annual Report Release Date and Investor Call
Feb 10, 2025

Ibi Inv House Ltd. has announced the publication date for its 2024 annual report, which will be released on March 24, 2025. The company will also hold an investor call on March 25, 2025, to review the annual report and provide a summary of the year 2024. This announcement signifies the company’s commitment to transparency and timely communication with its stakeholders. By providing clear timelines for the report and investor call, Ibi Inv House Ltd. is ensuring that investors and analysts are well-informed, which can positively impact its market perception.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Aug 18, 2025